Navigation Links
ATS Medical Announces Participation in the Annual Meeting of the American Association for Thoracic Surgeons

MINNEAPOLIS, May 8 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced participation in the upcoming Annual Meeting of the American Association for Thoracic Surgeons. One of the key gatherings of cardiovascular surgeons from around the world, the event is being held in San Diego from May 10-14, 2008.


The AATS meeting provides an excellent opportunity to demonstrate the progress made by ATS Medical in assembling an array of product offerings focused on the evolving needs of cardiac surgeons. The exhibition will feature the company's flagship ATS Open Pivot(R) Heart Valve and its newest advancement, the ATS Open Pivot(R) AP360(TM). The AP360 combines the fundamental strengths of the open pivot design with a new cuff that maximizes hemodynamic performance and extends the valve's appeal to a broader range of surgeon preferences.

The ATS 3f(R) Aortic Bioprosthesis will be the highlight of the exhibition. Professor Sven Martens from the JW Goethes University in Frankfurt will be presenting his "Single Center Experience with the ATS 3f(R) Enable(TM) Aortic Bioprosthesis" at the ATS booth on May 12 and 13.

The ATS Simulus(R) annuloplasty product line, designed for the heart valve repair market segment, will be showcased with special focus on the new ATS Simulus Semi-Rigid Annuloplasty Ring. Scott Goldman, M.D., from Lankenau Hospital in Philadelphia, will present his "Experience with ATS Simulus Annuloplasty Products and the ATS CryoMaze(TM) Surgical Ablation System" on Monday, May 12 during an in-booth presentation.

Atrial fibrillation is expected to be a key growth driver in 2008 and beyond. The ATS CryoMaze(TM) Surgical Ablation System, proven to yield clinical results similar to the conventional cut-and-sew Cox Maze III procedure, is being used by a growing number of surgeons as their therapy of choice. Edward Raines, M.D., of BryanLGH Medical Center in Lincoln, Nebraska, will present "A Practical Approach to Stand-Alone CryoMaze Prodecures via Mini-Thoracotomy" on May 13 at the ATS booth.

ATS Medical previously announced the first Frontiers in Cryoablation Symposium to be held in conjunction with the AATS on Sunday, May 11 with James Cox, M.D. and Niv Ad, M.D. co-moderating the program. Titled "Current Techniques, Robotics and the Future of Minimally Invasive Cryoablation," the symposium is sponsored collaboratively by ATS Medical and Intuitive Surgical, the makers of the da Vinci(R) Surgical System (Nasdaq: ISRG). The program will include a preeminent faculty of cardiac surgeons reporting on current techniques, robotics, and the future of minimally invasive cryoablation utilizing the ATS CryoMaze(TM) Surgical Ablation System.

About ATS Medical

ATS Medical, Inc. provides innovative products and services focused on cardiac surgery. The Company, global in scope, is headquartered in Minneapolis, Minnesota. More than 145,000 ATS Open Pivot(R) Heart Valves, which utilize a unique pivot design resulting in exceptional performance and low risk profile, have been implanted in patients worldwide. The ATS 3f(R) brand encompasses multiple tissue heart valve product offerings at varying steps from market introductions to clinical trials to development projects that incorporate less invasive valve replacement technology. ATS Medical's focus on serving the cardiac surgery community is further strengthened by offerings that include ATS Simulus(R) annuloplasty products for heart valve repair and ATS CryoMaze(TM) surgical ablation products. The ATS Medical web site is

Safe Harbor

This Press Release contains forward-looking statements that may include statements regarding intent, belief or current expectations of the Company and its management. Actual results could differ materially from those projected in the forward-looking statements as a result of a number of important factors, including the results of clinical trials, the timing of regulatory approvals, the integration of 3f Therapeutics and the surgical cryoablation business of CryoCath Technologies, Inc., regulatory actions, competition, pricing pressures, supplier actions and management of growth. For a discussion of these and other risks and uncertainties that could affect the Company's activities and results, please refer to the Company's filings with the Securities and Exchange Commission, including its Form 10-K for the year ended December 31, 2007 and its most recent quarterly report on Form 10-Q.

SOURCE ATS Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Culturesmart(TM) Breaks Language Barriers With Trained Medical Interpreters
2. Vail Valley Medical Center Board of Directors Announces Appointment of New President & CEO, John Cassin
3. Select Medical Corporation to Announce First Quarter Results on Thursday, May 15
4. Boston Medical Center/Boston University School of Medicine researcher receives award
5. Prisoner HIV program leads to continuum of medical care after release
6. Weill Cornell Medical College Announces First Commencement of Its New Medical School Graduates in Doha, Qatar, May 8, 2008
7. Medical research is essential to improving the economy and bettering lives
8. KePROs Chief Medical Officer to Deliver Clinical Keynote Address
9. ABQAURP Hosts Third Annual Medical Management Conference in Orlando
10. Warren F. Muth, MD, to Serve as President of Ohio State Medical Association
11. BioForm Medical Announces Extension of Lock-Up Period
Post Your Comments:
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users ... - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 ... Pro X . Simply select a ProHand generator and drag it above media or ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
(Date:6/25/2016)... ... , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department ... in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at ... Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 ...
(Date:6/24/2016)... Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... surgery procedures that most people are unfamiliar with. The article goes on to state ... procedures, but also many of these less common operations such as calf and cheek ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle ... chronic pain and the benefits of holistic treatments, Serenity Recovery Center of ... Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 ... Market by Type (Standard Pen Needles, Safety Pen Needles), ... (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) ... MarketsandMarkets, This report studies the market for the forecast ... to reach USD 2.81 Billion by 2021 from USD ...
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... Any dentist who has made an implant supported ... Many of them do not even offer this as a ... laboratory costs involved. And those who ARE able to offer ... high cost that the majority of today,s patients would not ... Zadeh , founder of Dental Evolutions Inc. and inventor of ...
Breaking Medicine Technology: